Clinical trial
High-Density Lipoprotein (HDL) Treatment Study
NCT00458055 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Completed
Key facts
| NCT number | NCT00458055 |
|---|---|
| Title | High-Density Lipoprotein (HDL) Treatment Study |
| Official title | Treatment Study for Severe High-Density Lipoprotein Deficiency |
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Coronary Arteriosclerosis, Hypoalphalipoproteinemias, Genetic Diseases, Inborn |
| Intervention type | Drug |
| Interventions | Atorvastatin, Fenofibrate, Niacin |
| Enrollment | 19 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 9, 2007 |
| Last update posted | Jun 4, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: